Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma (Q84783323)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 August 2011
edit
Language Label Description Also known as
English
Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma
scientific article published on 17 August 2011

    Statements

    title
    Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    21849487
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21849487%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    11 February 2020
    author
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q84783323&oldid=1858029822"